Valiant Laboratories Share Price
105.97+5.04 (+4.99%)
+21.96% past 1 Year
Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for
Corporate filings & documents
Announcements
Newspaper Advertisement regarding Completion of Dispatch of Annual Report for FY 2025-26 and Notice of 5th Annual General Meeting to the Members of the Company
2 hours agoCredit Rating issued by India Ratings & Research Private Limited
21 hours agoCredit Rating issued by India Ratings & Research Private Limited
21 hours agoLetter to Shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations 2015
21 hours agoLetter to Shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations 2015
21 hours agoNotice of 5th AGM and Annual Report for FY 2025-26
21 hours agoNotice of 5th AGM and Annual Report for FY 2025-26
21 hours agoAnnual Report for FY 2025-26.
21 hours agoAnnual Report for FY 2025-26.
21 hours agoNewspaper Advertisement w.r.t. 5th AGM of the Company.
4 days agoNewspaper Advertisement w.r.t. 5th AGM of the Company.
4 days agoCopy of Newspaper Publication of Financial Results for the quarter ended June 30 2026.
3 weeks agoCopy of Newspaper Publication of Financial Results for the quarter ended June 30 2026.
3 weeks agoMonitoring Agency Report for the quarter ended June 30 2026
3 weeks agoMonitoring Agency Report for the quarter ended June 30 2026
3 weeks agoOpening of a new Corporate Office of the Company
3 weeks agoOpening of a new Corporate Office of the Company
3 weeks agoChange in the Registered Office address of the Company subject to the approval of shareholders and other Statutory Authorities.
3 weeks agoChange in the Registered Office address of the Company subject to the approval of shareholders and other Statutory Authorities.
3 weeks agoInvestment in Wholly Owned Subsidiary.
3 weeks agoInvestment in Wholly Owned Subsidiary.
3 weeks agoRe-appointment of Managing Director Independent Director and Continuation of Directorship of Non- Executive Director.
3 weeks agoRe-appointment of Managing Director Independent Director and Continuation of Directorship of Non- Executive Director.
3 weeks agoAudited Standalone and Consolidated Financial Results for quarter ended June 30 2026.
3 weeks agoAudited Standalone and Consolidated Financial Results for quarter ended June 30 2026.
3 weeks agoAudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026.
3 weeks agoAudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026.
3 weeks agoValiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve financial results for Quarter ended June 30 2026
4 weeks agoValiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve financial results for Quarter ended June 30 2026
4 weeks agofor quarter ended June 30 2026.
1 month agofor quarter ended June 30 2026.
1 month agoClosure of Trading Window for declaration of Financial Results for the quarter ended June 30 2026.
2 months agoClosure of Trading Window for declaration of Financial Results for the quarter ended June 30 2026.
2 months agoPlease find enclosed
3 months agoAnnual Secretarial Compliance Report for the Financial Year 2025-2026.
3 months agoAnnual Secretarial Compliance Report for the Financial Year 2025-2026.
3 months agoThe Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Valiant Organics Ltd
3 months agoThe Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Valiant Organics Ltd
3 months agoPlease find enclosed
3 months agoValiant Laboratories Limited announces evaluation of Restructuring options.
3 months agoValiant Laboratories Limited announces evaluation of Restructuring options.
3 months agoCopy of Newspaper Publication of Financial Results for the quarter and year ended 31 March 2026.
3 months agoMonitoring Agency Report for quarter ended March 31 2026
3 months agoMonitoring Agency Report for quarter ended March 31 2026
3 months agoAudited Standalone and Consolidated Financial Results for quarter and year ended March 31 2026.
3 months agoAudited Standalone and Consolidated Financial Results for quarter and year ended March 31 2026.
3 months agoAppointment of Cost Auditor and Internal Auditor.
3 months agoAudited Standalone and Consolidated Financial Results for quarter and year ended March 31 2026.
3 months agoAudited Standalone and Consolidated Financial Results for the quarter and year ended March 31 2026.
3 months agoValiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve financial results for Quarter and Year ended March 31 2026
3 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-07-18
Rights
1:4;75.0 (Rights ratio;Offer price)
Company details
Registered office
109, Udyog Kshetra, First Floor Mulund Goregaon Link Road Mulund (West) Mumbai Maharashtra PIN: 400080 Tel No: 022-49712001 / 49717220 / 49717221 Fax No: NULL Email: [email protected] Internet: www.valiantorganics.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Mulesh M Savla, Non Executive Independent Director
Santosh S Vora, Managing Director
Paresh S Shah, Whole Time Director
Shantilal Shivji Vora, Non Executive Director
Sandeep Gupta, Non Executive Director
Sonal A Vira, Non Executive Independent Director
Akshay Gangurde, Company Secretary & Compliance Officer
Ashok Chheda, Non Executive Independent Director
Details
BSE 543998
NSE VALIANTLAB
ISIN INE0JWS01017